Abstract: Systems and methods affect tightening of the pyloric sphincter and/or serve to mediate or moderate receptive relaxation of muscles in the stomach, to treat or mitigate various physiologic conditions, such as obesity, biliary reflex, GERD, and/or Barrett's esophagus. The systems and methods may be used as either a primary treatment modality, or applied as a supplementary treatment before, during or after a primary intervention.
Type:
Grant
Filed:
November 8, 2002
Date of Patent:
December 23, 2008
Assignee:
Respiratory Diagnostic, Inc.
Inventors:
David S. Utley, Rachel E. Croft, John Gaiser
Abstract: A device for treating a tissue region is supplied with a separate usage key card. The usage key card comprises a storage medium, which is formatted to contain an identification code unique to the usage key card. The usage key card is adapted to be read by a remote reader, to download the identification code for processing by a controller for the device. Processing of the identification code by the controller either enables or disables operation of the device according to prescribed criteria.
Type:
Grant
Filed:
October 27, 2004
Date of Patent:
December 16, 2008
Assignee:
Respiratory Diagnostic, Inc.
Inventors:
Robin Bek, John Gaiser, Jay Qin, David S Utley
Abstract: An apparatus includes an expandable member. The expandable member is sized to be positionable in a sphincter. An energy delivery device is positioned on a surface of the expandable member. The energy delivery device has a configuration that provides sufficient energy delivery to create lesions in the interior of the sphincter. When the expandable member is removed from the sphincter, the sphincter returns to its closed or contracted configuration.
Abstract: Systems and methods apply a selected treatment agent or agents into contact with tissue at or in the region of a dysfunctional sphincter (in the case of GERD, fecal incontinence, or other dysfunctional sphincter disorders) to affect improved sphincter barrier function and/or to disrupt abnormal nerve pathways. The treatment agent can include at least one cytokine and/or at least one tissue bulking agent and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or applied as a supplementary treatment before, during or after a primary intervention.
Type:
Grant
Filed:
August 5, 2004
Date of Patent:
December 2, 2008
Assignee:
Respiratory Diagnostics, Inc.
Inventors:
David S Utley, John W Gaiser, Rachel Croft
Abstract: Systems and methods deploy a therapeutic or diagnostic element into contact with a body tissue region. The systems and methods can sense position of the therapeutic or diagnostic element relative to a targeted tissue region without direct or indirect visualization, by sensing fluid pressure in a fluid path having an outlet located at or near the therapeutic or diagnostic element. The systems and methods can also inflate the therapeutic or diagnostic element during use, while taking steps to avoid over-inflation and/or while dynamically monitoring the pressure conditions within the expanded element.
Type:
Grant
Filed:
April 26, 2005
Date of Patent:
September 9, 2008
Assignee:
Respiratory Diagnostic, Inc.
Inventors:
Robin Bek, John W. Gaiser, Scott H. West, Patrick Rimroth